EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Malignancy in Adults with Inborn Errors of Immunity: A Retrospective Single-Center Study

Reyhan Gumusburun, Onurcan Yıldırım, Metehan Karakoc, Kasım Okan, Sinem Inan, Ceyda Tunakan Dalgıc, Hatice Serpil Akten, Gulhan Bogatekin, Gokten Bulut, Meryem Demir, Hasibe Aytac, Asuman Camyar und 10 weitere

Journal of Clinical Immunology · 2025

DOI: 10.1007/s10875-025-01910-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Immunology, 2025. Verfasst von Reyhan Gumusburun und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Allergy and Clinical Immunology, Ege University Medical Faculty, Izmir, Turkey. reyhangumusburun@gmail.c…. Hauptthemen laut MEDLINE: Neoplasms, Primary Immunodeficiency Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Inborn Errors of Immunity (IEI) often lead to recurrent infections, immune dysregulation, and an increased risk of malignancies. Due to the heterogeneity in IEI presentations, personalized monitoring is essential for early detection of non-infectious complications. This study aims to document the characteristics and prevalence of malignancies in IEI patients. METHODS: A retrospective review of 355 patients diagnosed with IEI at the Adult Allergy and Immunology Clinic of Ege University was conducted. Data on demographics, clinical presentations, laboratory results, and immunological and genetic profiles of patients with malignancies were analyzed. RESULTS: A total of 40 patients with neoplasia (F/M: 18/22; median age: 51.58 years, range: 18-91) were evaluated. The median ages at IEI symptom onset, diagnosis, and neoplasm diagnosis were 16.5, 45, and 39.5 years, respectively. Malignancy was diagnosed in 60% of patients before IEI, with referrals for low immunoglobulin levels and/or severe infections, and for a genetic profile suggestive of immunodeficiency. The prevalence of malignancy in the overall cohort was 10.42% (37/355), while it was significantly higher in the common variable immunodeficiency (CVID) subgroup, reaching 20.44% (28/137). Lymphoma was the most common malignancy at 45.9%, primarily non-Hodgkin lymphoma (NHL) at 40.5%, with diffuse large B-cell lymphoma (DLBCL) as a key subtype; carcinomas were the second most common at 35.1%. Hematologic malignancies were significantly more frequent among patients with CVID (90.5%), whereas non-hematologic malignancies predominated in the non-CVID group (77.8%) (p = 0.024). Lymphoproliferation was more common in hematologic malignancies (85.7%) compared to non-hematologic malignancies (25.0%) (p < 0.001). Genetic variants were identified in 61% of cases, with 37% classified as pathogenic or likely pathogenic, including variants in TNFRSF13B/TACI, CCDC40, PLCG2, ATM, CARD11, CHEK2, CNV, COPB1, HPS5, LYST, MAPK8IP1, NBS1, NF1, NFKBIA, PI4KA, POLE, SPI1, and TAP2. CONCLUSIONS: Findings confirm that NHL, particularly DLBCL, is the most prevalent malignancy in this cohort. Given the link between malignancies and underlying IEI, immunologic evaluation is recommended, particularly for NHL patients. The observed predominance of hematologic malignancies among CVID patients and the association with lymphoproliferation further emphasize the need for heightened malignancy surveillance and early immunologic workup in this subgroup. Further research on biomarkers for malignancy prediction in IEI is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsPrimary Immunodeficiency DiseasesHumansAdultMaleFemaleMiddle AgedRetrospective StudiesAdolescentAgedYoung AdultAged, 80 and overPrevalence

Stichwörter der Autor:innen

IEIImmunodeficiencyMalignancyNon-Hodgkin LymphomaSecondary Immunodeficiency

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Allergy and Clinical Immunology, Ege University Medical Faculty, Izmir, Turkey. reyhangumusburun@gmail.com.
  • Department of Internal Medicine, Division of Allergy and Clinical Immunology, Ege University Medical Faculty, Izmir, Turkey.
  • Department of Internal Medicine, Ege University Faculty of Medicine, Izmir, Turkey.
  • Faculty of Medicine, Department of Pathology, Ege University, Izmir, Turkey. derya.demir@ege.edu.tr.
  • Department of Internal Medicine, Division of Hematology, Ege University Faculty of Medicine, Izmir, Turkey.
  • Faculty of Medicine, Department of Microbiology, Ege University, Izmir, Turkey. mehmet.soylu@ege.edu.tr.

Zitieren

APA

Gumusburun, R., Yıldırım, O., Karakoc, M., Okan, K., Inan, S., Dalgıc, C. T., Akten, H. S., Bogatekin, G., Bulut, G., Demir, M., Aytac, H., Camyar, A., Ozısık, M., Demir, D., Soyer, N., Soylu, M., Uysal, F. E., Aykut, A., Durmaz, A., …, & Ardeniz, O. (2025). Malignancy in Adults with Inborn Errors of Immunity: A Retrospective Single-Center Study. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-025-01910-1

Vancouver

Gumusburun R, Yıldırım O, Karakoc M, Okan K, Inan S, Dalgıc CT, et al. Malignancy in Adults with Inborn Errors of Immunity: A Retrospective Single-Center Study. Journal of Clinical Immunology. 2025. doi:10.1007/s10875-025-01910-1

BibTeX
@article{Gumusburun2025,
  author = {Gumusburun, Reyhan and Yıldırım, Onurcan and Karakoc, Metehan and Okan, Kasım and Inan, Sinem and Dalgıc, Ceyda Tunakan and Akten, Hatice Serpil and Bogatekin, Gulhan and Bulut, Gokten and Demir, Meryem and Aytac, Hasibe and Camyar, Asuman and Ozısık, Melih and Demir, Derya and Soyer, Nur and Soylu, Mehmet and Uysal, Funda Elmas and Aykut, Ayca and Durmaz, Asude and Ozgul, Semiha and Sin, Aytul Zerrin and Ardeniz, Omur},
  title = {Malignancy in Adults with Inborn Errors of Immunity: A Retrospective Single-Center Study},
  journal = {Journal of Clinical Immunology},
  year = {2025},
  doi = {10.1007/s10875-025-01910-1}
}
Kostenlos starten →